Changes in inflammatory markers following treatment of acute exacerbations of obstructive pulmonary disease
- 30 November 2001
- journal article
- clinical trial
- Published by Elsevier BV in Respiratory Medicine
- Vol. 95 (11), 891-897
- https://doi.org/10.1053/rmed.2001.1179
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Serum Eosinophil Cationic Protein Levels and Bronchodilator Responses at Acute Asthma ExacerbationAnnals of Allergy, Asthma & Immunology, 1997
- Bronchoscopic Evaluation of Severe AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Bronchial biopsies and airway inflammationEuropean Respiratory Journal, 1996
- Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.American Journal of Respiratory and Critical Care Medicine, 1996
- Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage.American Journal of Respiratory and Critical Care Medicine, 1995
- Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbationJournal of Allergy and Clinical Immunology, 1995
- Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow-volume curves, PC20, and exacerbationsRespiratory Medicine, 1994
- The development of an assay for human neutrophil lipocalin (HNL) — to be used as a specific marker of neutrophil activity in vivo and vitroJournal of Immunological Methods, 1994
- Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary diseaseJournal of Allergy and Clinical Immunology, 1993
- Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapyClinical and Experimental Allergy, 1993